unknown
Stage
About
EBVio is a preclinical therapeutics company developing novel precision medicines targeting Epstein-Barr virus-driven autoimmune diseases.
Explore EBVio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.